Dosing, Patient Satisfaction and Other Patient-Reported Outcomes after Switching to Rurioctocog Alfa Pegol in ATHN 2: A Longitudinal, Observational Study of Previously Treated Hemophilia Patients Switching Coagulation Replacement Factor Products

Author(s):
Janna M Journeycake, Michael Recht, Christine Guelcher, Ellis J Neufeld, Margaret V Ragni, Robert F Sidonio Jr, Cliff Takemoto, Michael D Tarantino, Dunlei Cheng, Susan Lattimore, Jorge Caicedo, Michael Denne
Publication:
Blood
Date:
November 5, 2020
Topics:
Dosing, Patient-Reported Outcome, Rurioctocog

Can’t find what you’re looking for?
Please contact support@athn.org for assistance.